Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

Go back to Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance
Gilead Sciences (NASDAQ: GILD) Delayed: 150.57 -2.1 (1.38%)
Previous Close $152.67    52 Week High $108.63 
Open $153.60    52 Week Low $71.39 
Day High $154.20    P/E 83.19 
Day Low $150.22    EPS $1.81 
Volume 2,209,772